So it is expected that LOXL2-e13 causes broad changes in mRNA expression profile, including some critical tumor-related genes, enabling LOXL2-e13 to play new and specific roles in ESCC compared to its wild-type counterpart. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.